Geelong 29 November | Shanghai Haohai Biological Technology (688366.SH) announced that, with the guarantee of not affecting the normal progress of the company's raised funds investment plan, the company plans to use temporarily idle raised funds not exceeding RMB 400 million for cash management, to purchase investment products with high security, good liquidity, and guaranteed principal (including but not limited to agreements deposits, notice deposits, time deposits, large-sum CDs, profit certificates, etc.), with a term not exceeding the construction period of the investment project, effective for 12 months from the date of approval by the board of directors. Within the aforementioned limit and timeframe, the company can use it in a revolving manner.